Old and new vaccine approaches
- 14 February 2003
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 3 (8) , 1195-1204
- https://doi.org/10.1016/s1567-5769(03)00016-x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Phase I Evaluation of Δ virG Shigella sonnei Live, Attenuated, Oral Vaccine Strain WRSS1 in Healthy AdultsInfection and Immunity, 2002
- Immunization with an Interferon??–gp120 Fusion Protein Induces Enhanced Immune Responses to Human Immunodeficiency Virus gp120The Journal of Infectious Diseases, 2001
- An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus RecombinantsCell, 2001
- Research note Schistosoma bovis: vaccine effects of a recombinant homologous glutathione S-transferase in sheepInternational Journal for Parasitology, 1999
- The development of Cop 1 (Copaxone®), and innovative drug for the treatment of multiple sclerosis: personal reflectionsImmunology Letters, 1996
- Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protectionVaccine, 1996
- Synthetic Recombinant Vaccines against Viral AgentsInternational Archives of Allergy and Immunology, 1995
- Peptide therapy for diabetes in NOD miceThe Lancet, 1994
- Comparative study of the immunogenicity and safety of two dosing schedules of Engerix-B hepatitis B vaccine in neonatesThe Pediatric Infectious Disease Journal, 1994
- Improved immunogenicity of a peptide epitope after fusion to hepatitis B core proteinNature, 1987